Phase 4 Crohn Disease trials recruiting now

All Crohn Disease trials, every phase

Other phases for Crohn Disease

Phase 4 Crohn Disease trials

• A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
  NCT07654751 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 3 locations
• A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
  NCT07310095 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.
  NCT06298461 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
  NCT05781152 · Phase: Phase 4 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 26 locations
• Combined Immunosuppression for Pediatric Crohn's Disease
  NCT05043870 · Phase: Phase 4 · Ages: 6 Years to 18 Years · Sex: All (male and female) · 1 location
• Control Crohn Safe Trial
  NCT03917303 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 6 locations
• Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease
  NCT06520397 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
  NCT06774079 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
  NCT06997965 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease
  NCT05928039 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations
• Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease
  NCT05552287 · Phase: Phase 4 · Ages: 1 Year to 15 Years · Sex: All (male and female) · 1 location
• Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
  NCT05906576 · Phase: Phase 4 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 1 location
• Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
  NCT05169593 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 28 locations
• Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
  NCT06113913 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 30 locations
• TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
  NCT06051253 · Phase: Phase 4 · Ages: 19 Years to 80 Years · Sex: All (male and female) · 1 location
• VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
  NCT06257706 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 69 locations

Common questions

What does Phase 4 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.